Skip to main content
SpringerLink
Log in

Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Foucar E, Rosai J, Dorfman R (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7(1):19–73

    CAS  PubMed  Google Scholar 

  2. Rubinstein M, Assal A, Scherba M, Elman J, White R, Verma A, Strakhan M, Mohammadi F, Janakiram M (2016) Lenalidomide in the treatment of Rosai Dorfman disease–a first in use report. Am J Hematol 91(2):E1. https://doi.org/10.1002/ajh.24225

    Article  PubMed  Google Scholar 

  3. Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS (2020) Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica 105(2):348–357. https://doi.org/10.3324/haematol.2019.219626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, Villivà N, Mandelli F (2002) Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 69(1):67–71

    Article  Google Scholar 

  5. Lima FB, Barcelos PSdV, Constâncio APN, Nogueira CD, Melo-Filho AA (2011) Rosai-Dorfman disease with spontaneous resolution: case report of a child. Rev Bras Hematol Hemoter 33(4):312–314. https://doi.org/10.5581/1516-8484.20110083

    Article  PubMed  PubMed Central  Google Scholar 

  6. Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131(26):2877–2890. https://doi.org/10.1182/blood-2018-03-839753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chen E, Pavlidakey P, Sami N (2016) Rosai-Dorfman disease successfully treated with thalidomide. JAAD Case Rep 2(5):369–372

    Article  Google Scholar 

  8. Shahidi-Dadras M, Hamedani B, Niknezhad N, Ghilizadeh N (2019) Rosai-Dorfman disease successfully treated with thalidomide: a case report. Dermatol Ther 32(5):e13005. https://doi.org/10.1111/dth.13005

    Article  PubMed  Google Scholar 

  9. Li X, Hong Y, An Q, Chen J, Wei H, Chen H-D, Gao X-H (2013) Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide. JAMA Dermatol 149(8):992–993. https://doi.org/10.1001/jamadermatol.2013.4399

    Article  PubMed  Google Scholar 

  10. Wei C, Zhou D-B (2021) Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases. Hematology 26(1):552–555. https://doi.org/10.1080/16078454.2021.1941552

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

    Ting Liu & Xinxin Cao

  2. State Key Laboratory of Complex Severe and Rare Diseases, Beijing, China

    Xinxin Cao

Authors
  1. Ting Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinxin Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xinxin Cao.

Ethics declarations

Ethics approval

This study was performed in accordance with the ethical standards of the Institutional Ethics Committee of Peking Union Medical College Hospital and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, T., Cao, X. Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report. Ann Hematol 101, 1351–1353 (2022). https://doi.org/10.1007/s00277-021-04719-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04719-1

Search

Navigation